Financial Enhancement Group LLC Bristol Myers Squibb CO Transaction History

Financial Enhancement Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$61.48 - $73.72 $1,414 - $1,695	-23 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $1,233 - $1,437	23 New	23 $1,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $46,192 - $52,344	-800 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $43,856 - $51,272	800 New	800 $47,000
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $71,954 - $89,683	-1,424 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $85,326 - $98,227	1,424 New	1,424 $90,000

2,536

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.